MNTA: Actually, I was "pinning my hopes" on 2 facts:
Lovenox, which generated 2.74 billion euros ($4.03 billion) in sales last year...
...Copaxone, which generated $2.26 billion in 2008.
Compare these 2 facts with the braggard CEO of another company who constantly claims that his developmental-stage product will garner billions in potential sales. You'd better hope that you are truly "charmed."